Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 106
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

ARMC5 selectively degrades SCAP-free SREBF1 and is essential for fatty acid desaturation in adipocytes

ARMC5 selectively degrades SCAP-free SREBF1 and is esse...

 82

Microglial STING is a central safeguard against neurological decline with age

Microglial STING is a central safeguard against neurolo...

 36

Innate versus adoptive competence: the controlled distribution of signalling receptors extends the concept of competence

Innate versus adoptive competence: the controlled distr...

 70